2-235494795-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001037131.3(AGAP1):c.109G>T(p.Val37Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000259 in 1,585,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001037131.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AGAP1 | NM_001037131.3 | c.109G>T | p.Val37Leu | missense_variant | 1/18 | ENST00000304032.13 | |
AGAP1 | NM_014914.5 | c.109G>T | p.Val37Leu | missense_variant | 1/17 | ||
AGAP1 | NM_001244888.2 | c.109G>T | p.Val37Leu | missense_variant | 1/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AGAP1 | ENST00000304032.13 | c.109G>T | p.Val37Leu | missense_variant | 1/18 | 5 | NM_001037131.3 |
Frequencies
GnomAD3 genomes AF: 0.000152 AC: 23AN: 151432Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000263 AC: 6AN: 227990Hom.: 0 AF XY: 0.00000803 AC XY: 1AN XY: 124460
GnomAD4 exome AF: 0.0000126 AC: 18AN: 1433616Hom.: 0 Cov.: 31 AF XY: 0.00000280 AC XY: 2AN XY: 713254
GnomAD4 genome AF: 0.000152 AC: 23AN: 151432Hom.: 0 Cov.: 29 AF XY: 0.000162 AC XY: 12AN XY: 73964
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2024 | The c.109G>T (p.V37L) alteration is located in exon 1 (coding exon 1) of the AGAP1 gene. This alteration results from a G to T substitution at nucleotide position 109, causing the valine (V) at amino acid position 37 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 06, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with AGAP1-related conditions. This variant is present in population databases (rs745570362, gnomAD 0.05%). This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 37 of the AGAP1 protein (p.Val37Leu). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at